OTCMKTS:UCBJF - UCB Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$88.67 0.00 (0.00 %)
(As of 02/18/2019 04:50 AM ET)
Previous Close$88.67
Today's Range$88.67 - $88.67
52-Week Range$73.6964 - $94.30
Average Volume1 shs
Market Capitalization$17.25 billion
P/E RatioN/A
Dividend YieldN/A
UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system. Its core products include Cimzia for rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis, and Crohn's disease; Vimpat, Keppra, and Briviact for epilepsy; and Neupro for Parkinson's disease and restless legs syndrome. The company also offers Zyrtec and Xyzal for allergy. Its product pipeline includes Evenity for the treatment of osteoporosis; bimekizumab for psoriasis, psoriatic arthritis, and ankylosing spondylitis diseases; dapirolizumab pegol for systemic lupus erythematosus; padsevonil for highly drug resistant epilepsy; seletalisib for Sjögren's syndrome; rozanolixizumab for immune thrombocytopenia; UCB4144/VR942 for asthma; UCB6673, UCB7858, and UCB0159 for the treatment of neurology; and UCB3491 and UCB0599 for bone treatment. The company has a collaboration agreement with Enable Injections, Inc. UCB SA was founded in 1928 and is based in Brussels, Belgium.

Receive UCBJF News and Ratings via Email

Sign-up to receive the latest news and ratings for UCBJF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual Sales$4.55 billion
Cash Flow$3.3587 per share



Market Cap$17.25 billion
OptionableNot Optionable

UCB (OTCMKTS:UCBJF) Frequently Asked Questions

What is UCB's stock symbol?

UCB trades on the OTCMKTS under the ticker symbol "UCBJF."

What is the consensus analysts' recommendation for UCB?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UCB in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for UCB.

Has UCB been receiving favorable news coverage?

News stories about UCBJF stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. UCB earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.

Who are some of UCB's key competitors?

Who are UCB's key executives?

UCB's management team includes the folowing people:
  • Mr. Jean-Christophe Tellier, Chief Exec. Officer and Exec. Director (Age 60)
  • Mr. Detlef Thielgen, CFO & Exec. VP (Age 59)
  • Mr. Charl Van Zyl, COO & Exec. VP (Age 52)
  • Dr. Bharat Tewarie, Chief Marketing Officer & Exec. VP (Age 58)
  • Prof. Iris Löw-Friedrich, Chief Medical Officer, Head of Devel. & Medical Patient Value Practices and Exec. VP (Age 59)

How do I buy shares of UCB?

Shares of UCBJF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is UCB's stock price today?

One share of UCBJF stock can currently be purchased for approximately $88.67.

How big of a company is UCB?

UCB has a market capitalization of $17.25 billion and generates $4.55 billion in revenue each year.

What is UCB's official website?

The official website for UCB is http://www.ucb.com.

How can I contact UCB?

UCB's mailing address is 60 ALLEE DE LA RECHERCHE, BRUSSELS C9, 1070. The company can be reached via phone at 32-2559-9999 or via email at [email protected]

MarketBeat Community Rating for UCB (OTCMKTS UCBJF)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  167 (Vote Underperform)
Total Votes:  308
MarketBeat's community ratings are surveys of what our community members think about UCB and other stocks. Vote "Outperform" if you believe UCBJF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UCBJF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: Front-End Load

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel